Amylyx Pharmaceuticals, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of the securities of Amylyx Pharmaceuticals, Inc. (“Amylyx” or the “Company”) (NASDAQ: AMLX) between November 11, 2022 and November 8, 2023 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
Inari Medical, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)(NASDAQ: NARI). Click Here to Join Investigation…. Read MoreJoin Investigation
The Chemours Company Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)(NYSE: CC). Click Here To Join Investigation…. Read MoreJoin Investigation
Dick’s Sporting Goods, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers of Dick’s Sporting Goods, Inc. (“DSG” or the “Company”)(NYSE: DKS) common stock between May 25, 2022 and August 21, 2023, inclusive (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
New York Community Bancorp, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of New York Community Bancorp, Inc. (“NYCB” or the “Company”)(NYSE: NYCB). Click Here to Join Investigation…. Read MoreJoin Investigation
Brooge Energy Limited Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of the securities of Brooge Energy Limited (“Brooge” or the “Company”) (NASDAQ: BROG) between November 25, 2019 and December 21, 2023, inclusive (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
iRhythm Technologies, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of the common stock of iRhythm Technologies, Inc. (“iRhythm” or the “Company”)(NASDAQ: IRTC) between January 11, 2022 and May 30, 2023, inclusive (the “Class Period”). iRhythm is a digital healthcare company that develops and manufactures heart monitoring devices designed to diagnose arrhythmias. Click Here to Join Investigation…. Read MoreJoin Investigation
Xponential Fitness, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers of Xponential Fitness, Inc.’s (“Xponential Fitness” or the “Company”) publicly traded Class A common stock (NYSE: XPOF) between July 26, 2021 and December 7, 2023, inclusive (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation